Anagrelide (Compound)

Synonyms:anagrelide, 68475-42-3, Anagrelida, Xagrid, Anagrelidum, 6,7-Dichloro-5,10-dihydroimidazo[2,1-b]quinazolin-2(3H)-one, UNII-K9X45X0051, CHEMBL760, 6,7-Dichloro-1,5-dihydroimidazo(2,1-b)quinazolin-2(3H)-one, CHEBI:142290, Imidazo[2,1-b]quinazolin-2(3H)-one, 6,7-dichloro-1,5-dihydro-, K9X45X0051, Anagrelide [INN:BAN], Anagrelidum [INN-Latin], Anagrelida [INN-Spanish], 6,7-Dichloro-1,5-dihydroimidazo[2,1-b]quinazolin-2(3H)-one, 6,7-bis(chloranyl)-3,5-dihydro-1H-imidazo[2,1-b]quinazolin-2-one, Imidazo(2,1-b)quinazolin-2(3H)-one, 6,7-dichloro-1,5-dihydro-, C10H7Cl2N3O, HSDB 7325, BL 416201, Anagrelide (INN/BAN), BRN 0619582, 6,7-dichloro-1,5-dihydroimidazo[2,1-b]quinazolin-2[3H]-one, 6,7-Dichlor-1,5-dihydroimidazo(2,1-b)chinazolin-2(3H)-on, 6,7-dichloro-5,10-dihydro-3H-imidazo[2,1-b]quinazolin-2-one, SCHEMBL9411, BIDD:GT0711, GTPL7114, 6,7-dichloro-1,5-dihydroimidazo[2,1-]quinazolin-2(3H)-one, 6,7-dichloro-3,5-dihydroimidazo[2,1-b]quinazolin-2(1H)-one, HMS2089D21, HMS3715J06, HMS3742K13, BCP21314, ZINC3871541, BDBM50000334, MFCD00866794, AKOS015899342, AKOS016340524, AC-3401, CCG-221242, DB00261, KS-5176, NCGC00161408-02, NCGC00161408-08, NCGC00247665-01, AS-14157, K139, SBI-0206823.P001, AB0014050, DB-055153, FT-0602855, FT-0630776, D07455, AB00698496-05, AB00698496-07, AB00698496_08, AB01566808_01, 475A423, A915719, Q408163, 6,7-dichloro-3H,5H-imidazo[2,1-b]quinazolin-2-ol, BRD-K62200014-003-05-5, BRD-K62200014-003-08-9, 6,7-Dichloro-1,5-dihydro-imidazo[2,1-b]quinazolin-2-one, 6,7-dichloro-1h,5h-imidazo[2,1-b]quinazoline-2(3h)-one, 6,7-dichloro-1, 5-dihydroimidazo[2,1-b]quinazolin-2[3H]-one, 6,7-Dichloro-1,5-dihydroimidazo[2,1-b]-quinazolin-2(3H)-one, 6,7-dichloro-1,5dihydroimidazo[2,1-b]quinazolin-2[3H]-one, 6,7-dichloro-1H,2H,3H,5H-imidazolidino[2,1-b]quinazolin-2-one, Imidazo[2,1-b]quinazolin-2(3H)-one,6,7-dichloro-1,5-dihydro-, 6,7-di-chloro-1,5-dihydroimidazo[2,1-b]quinazolin-2[3 H ]-one base, 6,7-Dichloro-1,5-dihydro-imidazo[2,1-b]quinazolin-2-one(anagrelide), 6,7-Dichloro-1,5-dihydro-imidazo[2,1-b]quinazolin-2-one(BL-4162A), J33

Pubchem:PUBCHEM:135409400

Id:135409400

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Anagrelide's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Anagrelide.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Anagrelide.

Results found

Linked to

	Label	Description
	BRD-K62200014-003-05-5 Substance (Entity type)	A Substance
	DCSTRUCT ID 00209 Collection (Entity type)	DrugPage Collection: (DrugCentralID:00209; PubChem_CID:135409400, FILE=drugcentral_drug_00209.json)
	anagrelide (ede62f47-e407-4f2b-8c33-fd930560a392) Collection (Entity type)	Metadatata for anagrelide
	Anagrelide positively regulates SRM Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Anagrelide positively regulates BCAT1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Anagrelide negatively regulates HSPB1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Anagrelide negatively regulates CYP1B1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Anagrelide positively regulates NUSAP1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Anagrelide negatively regulates KRT18 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Anagrelide positively regulates SPARCL1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS